Inhibitor of apoptosis-stimulating protein of p53 (iASPP) prevents senescence and is required for epithelial stratification

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 40, 2011, Pages 16645-16650

  Notari, Mario ^a   Hu, Ying ^a   Koch, Sofia ^a   Lu, Min ^a   Ratnayaka, Indrika ^a   Zhong, Shan ^a   Baer, Caroline ^a   Pagotto, Anna ^a   Goldin, Robert ^b   Salter, Victoria ^a   Candi, Eleonora ^c   Melino, Gerry ^c,d   Lu, Xin ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INHIBITOR OF APOPTOSIS STIMULATING PROTEIN OF P53; INVOLUCRIN; LORICRIN; PROTEIN P53; PROTEIN P63; UNCLASSIFIED DRUG;

ARTICLE; CELL AGING; CELL DIFFERENTIATION; GENE CONTROL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANIMALS; CELL AGING; CELL DIFFERENTIATION; EPITHELIUM; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KERATINOCYTES; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; PROTEIN PRECURSORS; REPRESSOR PROTEINS; TRANSCRIPTION FACTOR RELA;

MUS MUSCULUS;

EID: 80053619221     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1102292108     Document Type: Article

References (37)

1. Levine AJ, Oren M (2009) The first 30 years of p53: Growing ever more complex. Nat Rev Cancer 9:749-758.
2. Belyi VA, Levine AJ (2009) One billion years of p53/p63/p73 evolution. Proc Natl Acad Sci USA 106:17609-17610.
3. Bergamaschi D, et al. (2003) iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat Genet 33:162-167. (Pubitemid 36177067)
4. Sullivan A, Lu X (2007) ASPP: A new family of oncogenes and tumour suppressor genes. Br J Cancer 96:196-200. (Pubitemid 46160620)
5. Murray-Zmijewski F, Lane DP, Bourdon JC (2006) p53/p63/p73 isoforms: An orchestra of isoforms to harmonise cell differentiation and response to stress. Cell Death Differ 13:962-972.
6. Carroll DK, et al. (2006) p63 regulates an adhesion programme and cell survival in epithelial cells. Nat Cell Biol 8:551-561. (Pubitemid 43827347)
7. Mills AA, et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713. (Pubitemid 29197649)
8. Yang A, et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-718. (Pubitemid 29197650)
9. Yang A, et al. (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature 404:99-103. (Pubitemid 30143141)
10. Bergamaschi D, et al. (2004) ASPP1 and ASPP2: Common activators of p53 family members. Mol Cell Biol 24:1341-1350. (Pubitemid 38112194)
11. Kampa KM, et al. (2009) Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds. Proc Natl Acad Sci USA 106:4390-4395.
12. Vives V, et al. (2006) ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes Dev 20:1262-1267. (Pubitemid 43727587)
13. Robinson RA, Lu X, Jones EY, Siebold C (2008) Biochemical and structural studies of ASPP proteins reveal differential binding to p53, p63, and p73. Structure 16:259-268. (Pubitemid 351215211)
14. Yang JP, Hori M, Sanda T, Okamoto T (1999) Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J Biol Chem 274:15662-15670.
15. Baldwin AS, Jr., Azizkhan JC, Jensen DE, Beg AA, Coodly LR (1991) Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts. Mol Cell Biol 11:4943-4951. (Pubitemid 21895255)
16. Duckett CS, Perkins ND, Leung K, Agranoff AB, Nabel GJ (1995) Cytokine induction of nuclear factor kappa B in cycling and growth-arrested cells. Evidence for cell cyclein-dependent activation. J Biol Chem 270:18836-18840.
17. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D (1995) Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 376:167-170.
18. Dohn M, Zhang S, Chen X (2001) p63alpha and DeltaNp63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes. Oncogene 20:3193-3205. (Pubitemid 32553672)
19. Guo X, et al. (2009) TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat Cell Biol 11:1451-1457.
20. Candi E, et al. (2006) p63 is upstream of IKK alpha in epidermal development. J Cell Sci 119(Pt 22, 119Pt 22)4617-4622.
21. Herron BJ, et al. (2005) A mutation in NFkB interacting protein 1 results in cardiomyopathy and abnormal skin development in wa3 mice. Hum Mol Genet 14:667-677. (Pubitemid 40309592)
22. Schwenk F, Baron U, Rajewsky K (1995) A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res 23:5080-5081. (Pubitemid 26012492)
23. Indra AK, et al. (1999) Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: Comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases. Nucleic Acids Res 27:4324-4327. (Pubitemid 29533170)
24. Hennings H, Holbrook K, Steinert P, Yuspa S (1980) Growth and differentiation of mouse epidermal cells in culture: Effects of extracellular calcium. Curr Probl Dermatol 10:3-25.
25. Yang A, et al. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316. (Pubitemid 128379271)
26. Koster MI, Kim S, Mills AA, DeMayo FJ, Roop DR (2004) p63 is the molecular switch for initiation of an epithelial stratification program. Genes Dev 18:126-131. (Pubitemid 38141780)
27. Fuchs E, Green H (1980) Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 19:1033-1042. (Pubitemid 10155237)
28. Owens DW, Brunton VG, Parkinson EK, Frame MC (2000) E-cadherin at the cell periphery is a determinant of keratinocyte differentiation in vitro. Biochem Biophys Res Commun 269:369-376. (Pubitemid 30440306)
29. Squier CA, Kremer MJ (2001) Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 29:7-15.
30. Osada M, et al. (2005) Differential recognition of response elements determines target gene specificity for p53 and p63. Mol Cell Biol 25:6077-6089. (Pubitemid 40946559)
31. Candi E, et al. (2006) Differential roles of p63 isoforms in epidermal development: Selective genetic complementation in p63 null mice. Cell Death Differ 13:1037-1047.
32. Murray-Zmijewski F, Slee EA, Lu X (2008) A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol 9:702-712.
33. Candi E, et al. (2008) p63 in epithelial development. Cell Mol Life Sci 65:3126-3133.
34. King KE, et al. (2003) deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes. Oncogene 22:3635-3644. (Pubitemid 36765323)
35. Nylander K, et al. (2002) Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol 198:417-427. (Pubitemid 35446994)
36. Su X, et al. (2009) TAp63 prevents premature aging by promoting adult stem cell maintenance. Cell Stem Cell 5:64-75.
37. Descargues P, Sil AK, Karin M (2008) IKKalpha, a critical regulator of epidermal differentiation and a suppressor of skin cancer. EMBO J 27:2639-2647.